Analysis of risk factors for early mortality after orthotopic liver transplantation

doi:10.3877/cma.j.issn.1674-0793.2026.03.002

Abstract

Abstract:

Objective

To explore the potential risk factors for mortality within 30 days after orthotopic liver transplantation (OLT) and provide scientific basis for formulating individualized perioperative intervention strategies and predicting postoperative risks.

Methods

This retrospective study included recipients who underwent OLT at Beijing Chao-Yang Hospital, Capital Medical University. Death within 30 days after surgery was defined as early postoperative mortality, and patients were grouped accordingly. General patient information, preoperative laboratory indicators, and intraoperative data were collected. Receiver operating characteristic (ROC) curves were used to determine the optimal cutoff values for each indicator. Least absolute shrinkage and selection operator (LASSO) regression was applied to screen factors relevant to early postoperative mortality, followed by univariate and multivariate Logistic regression analysis to identify independent risk factors. Restricted cubic spline (RCS) analysis was employed to examine the dose-response relationships between these factors and the risk of early mortality.

Results

A total of 535 OLT recipients were included, among whom 36 (6.7%) experienced early postoperative mortality. Multivariate Logistic regression analysis revealed that intraoperative erythrocyte transfusion >1 650 ml (OR=3.313, 95% CI: 1.397-7.857), intraoperative urine volume≤1 115 ml (OR=3.245, 95% CI: 1.409-7.473), preoperative platelet count≤24.5×10⁹/L (OR=3.437, 95% CI: 1.194-9.895), and preoperative blood glucose≤4.8 mmol/L (OR=2.955, 95% CI: 1.286-6.791) were independent risk factors for early postoperative mortality after OLT. RCS analysis indicated that intraoperative erythrocyte transfusion volume and urine volume showed linear correlations with the risk of early postoperative mortality, while preoperative platelet count exhibited a nonlinear correlation with the risk of early postoperative mortality.

Conclusions

Low preoperative platelet count, preoperative hypoglycemia, high intraoperative erythrocyte transfusion volume, and low intraoperative urine volume are independent risk factors for early postoperative mortality. Preoperative measures should be taken to increase platelet counts above 24.5×10⁹/L, while the optimal range for perioperative blood glucose requires further clarification.

Key words: Liver transplantation, Early mortality, Risk factors, Platelet count, Preoperative blood glucose, Erythrocyte transfusion volume, Intraoperative urine output

Xun Liu, Liang Bi, Ren Lang, Anshi Wu. Analysis of risk factors for early mortality after orthotopic liver transplantation[J]. Chinese Archives of General Surgery(Electronic Edition), 2026, 20(03): 150-156.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2026.03.002

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2026/V20/I03/150

Figures/Tables 4

References 34

［1］	Liu J, Li J, Su W, et al. Nomogram prediction for postoperative mortality of orthotopic liver transplantation[J]. Exp Clin Transplant, 2022, 20(12): 1099–1104.
［2］	Caballero M, Sabate A, Gutierrez R, et al. Blood component requirements in liver transplantation: effect of 2 thromboelastometry-guided strategies for bolus fibrinogen infusion: the TROMBOFIB randomized trial[J]. J Thromb Haemost, 2023, 21(1): 37–46.
［3］	Jóźwik A, Karpeta E, Nita M, et al. Impact of blood loss and intraoperative blood transfusion during liver transplantation on the incidence of early biliary complications and mortality[J]. Transplant Proc, 2020, 52(8): 2477–2479.
［4］	Tan L, Wei X, Yue J, et al. Impact of perioperative massive transfusion on long term outcomes of liver transplantation: A retrospective cohort study[J]. Int J Med Sci, 2021, 18(16): 3780–3787.
［5］	王孟龙. 门静脉高压症肝脏血供改变对肝移植的影响与对策[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(5): 687-692.
［6］	谭凯. 成人首次肝移植术后早期死亡的相关因素分析[D]. 广州: 南方医科大学, 2012.
［7］	谭永法, 周杰, 谭凯, 等. 成人首次肝移植术后早期预后分析[J]. 中华消化外科杂志, 2012, 11(6): 541–545.
［8］	Zeng J, Li Q, Wu Q, et al. A novel online calculator predicting acute kidney injury after liver transplantation: A retrospective study[J]. Transpl Int, 2023, 36: 10887.
［9］	陈怡宁, 张慧, 康俊伟, 等. 原位肝移植后发生早期急性肾损伤危险因素及预后分析[J]. 中华消化外科杂志, 2024, 23(7): 952–960.
［10］	Nilles KM, Flamm SL. Thrombocytopenia in chronic liver disease new management strategies[J]. Clin Liver Dis, 2020, 24(3): 437–451.
［11］	Ding Z, Wu H, Zeng Y, et al. Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures[J]. Hepatol Int, 2023, 17(1): 180–189.
［12］	Scharf RE. Thrombocytopenia and hemostatic changes in acute and chronic liver disease: pathophysiology, clinical and laboratory features, and management[J]. J Clin Med, 2021, 10(7): 1530.
［13］	Estcourt LJ, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions[J]. Br J Haematol, 2017, 176(3): 365–394.
［14］	Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: A clinical practice guideline from the AABB[J]. Ann Intern Med, 2015, 162(3): 205–213.
［15］	Takahashi K, Liang C, Oda T, et al. Platelet and liver regeneration after liver surgery[J]. Surg Today, 2020, 50(9): 974–983.
［16］	Frick J, Frobert A, Quintela Pousa AM, et al. Evidence for platelet-derived transforming growth factor β1 as an early inducer of liver regeneration after hepatectomy in mice[J]. FASEB J, 2024, 38(17): e70039.
［17］	Gwiasda J, Schrem H, Klempnauer J, et al. Identifying independent risk factors for graft loss after primary liver transplantation[J]. Langenbecks Arch Surg, 2017, 402(5): 757–766.
［18］	Zahr Eldeen F, Roll GR, Derosas C, et al. Preoperative thromboelastography as a sensitive tool predicting those at risk of developing early hepatic artery thrombosis after adult liver transplantation[J]. Transplantation, 2016, 100(11): 2382–2390.
［19］	Gallo P, Terracciani F, Di Pasquale G, et al. Thrombocytopenia in chronic liver disease: physiopathology and new therapeutic strategies before invasive procedures[J]. World J Gastroenterol, 2022, 28(30): 4061–4074.
［20］	Chin JL, Hisamuddin SH, O’Sullivan A, et al. Thrombocytopenia, platelet transfusion, and outcome following liver transplantation[J]. Clin Appl Thromb Hemost, 2016, 22(4): 351–360.
［21］	Zheng W, Zhao KM, Luo LH, et al. Perioperative single-donor platelet apheresis and red blood cell transfusion impact on 90-day and overall survival in living donor liver transplantation[J]. Chin Med J (Engl), 2018, 131(4): 426–434.
［22］	中华医学会器官移植学分会围手术期管理学组. 成人肝移植围手术期麻醉管理专家共识(2021版)[J]. 中华器官移植杂志, 2021, 42(6): 329–335.
［23］	Shen LX, Wu YG, Ke MD. The liver disease-related hypoglycemia: An overview of the impact, management approaches, and underlying mechanisms[J]. Br J Hosp Med, 2025, 86(6): 1–18.
［24］	Govindarajan R, Chen J, Zhang K, et al. Association between hypoglycemia and poor clinical outcomes in hospitalized non-diabetic patients with liver cirrhosis: A narrative review[J]. Front Med (Lausanne), 2025, 12: 1541471.
［25］	Moreau R, Clària J, Aguilar F, et al. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF[J]. J Hepatol, 2020, 72(4): 688–701.
［26］	Gökdemir BN, Çekmen N. Vasoplegic syndrome and anaesthesia: A narrative review[J]. Turk J Anaesthesiol Reanim, 2023, 51(4): 280–289.
［27］	Ronca V, Wootton G, Milani C, et al. The immunological basis of liver allograft rejection[J]. Front Immunol, 2020, 11: 2155.
［28］	Verhulst CEM, van Heck JIP, Fabricius TW, et al. Sustained proinflammatory effects of hypoglycemia in people with type 2 diabetes and in people without diabetes[J]. Diabetes, 2022, 71(12): 2716–2727.
［29］	Bathgate AJ, Lee P, Hayes PC, et al. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation[J]. Liver Transpl, 2000, 6(6): 721–727.
［30］	Mao JX, Guo WY, Guo M, et al. Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients[J]. Hepatol Int, 2020, 14(3): 347–361.
［31］	Saiman Y, Mahmud N. Hypoglycemia is an early, independent predictor of bacteremia and in-hospital death in patients with cirrhosis[J]. Eur J Gastroenterol Hepatol, 2021, 33(1S Suppl 1): e693-e699.
［32］	Xiang Z, Song Y, Liu J, et al. Impact of preoperative infection on the outcomes of liver transplant recipients: A national propensity score-matched retrospective cohort study in China[J]. Int J Surg, 2024, 110(4): 2196–2206.
［33］	闫学丽,孔德莹,胡颖辉,等. 原位肝移植术后即时并发症发生情况及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(6): 894-901.
［34］	Duan Y, Cui L, Li Z, et al. Impact of differential glycemic management goals in pre-anhepatic and anhepatic phase on early grafted liver function after liver transplantation: An open-label, randomized, controlled study[J]. J Clin Anesth, 2025, 103: 111807.

变量	早期生存组(499例)	早期死亡组(36例)	统计量	P值
一般情况
年龄(岁)^a	53.0 (46.0, 59.5)	51.5 (42.3, 59.5)	-0.97	0.331
性别^b			0.60	0.437
女	98 (19.6)	9 (25.0)
男	401 (80.4)	27 (75.0)
BMI (kg/m²)^a	24.1 (21.8, 26.3)	24.2 (21.5, 26.0)	-0.43	0.667
MELD评分 (分)^a	14.1 (9.0, 21.6)	22.6 (14.5, 32.1)	-3.64	<0.001^c
肝脏原发疾病^b
肝细胞癌	214 (42.9)	10 (27.8)	3.15	0.076
乙型肝炎肝硬化	112 (22.44)	9 (25.00)	0.13	0.723
酒精性肝硬化	48 (9.62)	8 (22.22)	4.43	0.035^c
自身免疫性肝硬化	27 (5.41)	3 (8.33)	0.13	0.718
急性肝衰竭	30 (6.01)	2 (5.56)	<0.001	1.000
合并症^b
高血压	93 (18.64)	8 (22.22)	0.28	0.596
糖尿病	108 (21.64)	7 (19.44)	0.10	0.756
门静脉高压症	268 (53.71)	22 (61.11)	0.74	0.389
脾功能亢进	196 (39.28)	9 (25.00)	2.90	0.089
腹腔积液	251 (50.30)	22 (61.11)	1.57	0.210
肺部感染	37 (7.41)	6 (16.67)	2.74	0.098
腹腔感染	12 (2.40)	5 (13.89)	10.90	<0.001^c
肝肾综合征	25 (5.01)	6 (16.67)	6.36	0.012^c
肝性脑病	67 (13.43)	12 (33.33)	10.57	0.001^c
上消化道出血	37 (7.41)	4 (11.11)	0.23	0.631
术前辅助检查^a
血红蛋白 (g/L)	105.4 (82.5, 129.5)	93.0 (75.0, 120.0)	-1.93	0.053
血小板计数 (×10⁹/L)	66.0 (43.5, 122.5)	56.5 (28.5, 90.0)	-2.00	0.046^c
AST (U/L)	47.00 (32.0, 88.0)	57.50 (44.8, 147.6)	-2.33	0.020^c
ALT (U/L)	30.0 (20.0, 53.0)	41.5 (20.8, 84.8)	-1.71	0.087
总胆红素 (μmol/L)	54.5 (22.7, 305.6)	251.8 (36.2, 504.4)	-3.08	0.002^c
白蛋白 (g/L)	33.6 (29.5, 37.2)	30.6 (25.9, 33.8)	-3.18	<0.001^c
血肌酐 (μmol/L)	65.4 (54.1, 80.0)	78.47 (55.8, 167.1)	-2.15	0.032^c
血糖 (mmol/L)	6.4 (5.1, 6.5)	6.4 (4.6, 6.4)	-1.57	0.116
血钾 (mmol/L)	3.9 (3.6, 4.2)	3.8 (3.5, 4.1)	-0.87	0.386
凝血酶原活动度 (%)	62.4 (45.7, 77.6)	58.5 (32.2, 70.3)	-2.23	0.026^c
部分凝血酶活化时间 (s)	36.5 (30.0, 48.4)	51.6 (35.5, 78.7)	-3.51	<0.001^c
纤维蛋白原 (g/L)	1. 6 (1.1, 2.2)	1.2 (0.8, 1.8)	-2.01	0.044^c
术中情况^a
手术时长 (min)	472.5 (407.5, 550.0)	485.0 (435.0, 560.0)	-1.64	0.100
功能性热缺血时间 (min)	3.0 (2.0, 3.0)	3.0 (3.0, 3.0)	-0.63	0.525
冷缺血时间 (h)	6.0 (4.0, 7.0)	6.0 (4.0, 8.0)	-0.06	0.952
无肝期时长 (min)	119.0 (101.3, 144.3)	130.0 (108.0, 155.0)	-1.42	0.155
红细胞输注量 (ml)	800.0 (0.0, 1 600.0)	1 600.0 (800.0, 2 100.0)	-3.63	<0.001^c
输血浆量 (ml)	800.0 (400.0, 800.0)	800.0 (800.0, 1 200.0)	-2.22	0.027^c
输液量 (ml)	5 100.0 (4 300.0, 6 300.0)	4 325.0 (3 525.0, 5 825.0)	-3.35	0.001^c
出血量 (ml)	800.0 (500.0, 1 200.0)	1 100.0 (800.0, 1 700.0)	-2.88	0.004^c
尿量 (ml)	1 668.8 (1 140.0, 2 200.0)	935.0 (462.5, 1 623.75)	-4.65	<0.001^c

变量	早期生存组(499例)	早期死亡组(36例)	统计量	P值
一般情况
年龄(岁)^a	53.0 (46.0, 59.5)	51.5 (42.3, 59.5)	-0.97	0.331
性别^b			0.60	0.437
女	98 (19.6)	9 (25.0)
男	401 (80.4)	27 (75.0)
BMI (kg/m²)^a	24.1 (21.8, 26.3)	24.2 (21.5, 26.0)	-0.43	0.667
MELD评分 (分)^a	14.1 (9.0, 21.6)	22.6 (14.5, 32.1)	-3.64	<0.001^c
肝脏原发疾病^b
肝细胞癌	214 (42.9)	10 (27.8)	3.15	0.076
乙型肝炎肝硬化	112 (22.44)	9 (25.00)	0.13	0.723
酒精性肝硬化	48 (9.62)	8 (22.22)	4.43	0.035^c
自身免疫性肝硬化	27 (5.41)	3 (8.33)	0.13	0.718
急性肝衰竭	30 (6.01)	2 (5.56)	<0.001	1.000
合并症^b
高血压	93 (18.64)	8 (22.22)	0.28	0.596
糖尿病	108 (21.64)	7 (19.44)	0.10	0.756
门静脉高压症	268 (53.71)	22 (61.11)	0.74	0.389
脾功能亢进	196 (39.28)	9 (25.00)	2.90	0.089
腹腔积液	251 (50.30)	22 (61.11)	1.57	0.210
肺部感染	37 (7.41)	6 (16.67)	2.74	0.098
腹腔感染	12 (2.40)	5 (13.89)	10.90	<0.001^c
肝肾综合征	25 (5.01)	6 (16.67)	6.36	0.012^c
肝性脑病	67 (13.43)	12 (33.33)	10.57	0.001^c
上消化道出血	37 (7.41)	4 (11.11)	0.23	0.631
术前辅助检查^a
血红蛋白 (g/L)	105.4 (82.5, 129.5)	93.0 (75.0, 120.0)	-1.93	0.053
血小板计数 (×10⁹/L)	66.0 (43.5, 122.5)	56.5 (28.5, 90.0)	-2.00	0.046^c
AST (U/L)	47.00 (32.0, 88.0)	57.50 (44.8, 147.6)	-2.33	0.020^c
ALT (U/L)	30.0 (20.0, 53.0)	41.5 (20.8, 84.8)	-1.71	0.087
总胆红素 (μmol/L)	54.5 (22.7, 305.6)	251.8 (36.2, 504.4)	-3.08	0.002^c
白蛋白 (g/L)	33.6 (29.5, 37.2)	30.6 (25.9, 33.8)	-3.18	<0.001^c
血肌酐 (μmol/L)	65.4 (54.1, 80.0)	78.47 (55.8, 167.1)	-2.15	0.032^c
血糖 (mmol/L)	6.4 (5.1, 6.5)	6.4 (4.6, 6.4)	-1.57	0.116
血钾 (mmol/L)	3.9 (3.6, 4.2)	3.8 (3.5, 4.1)	-0.87	0.386
凝血酶原活动度 (%)	62.4 (45.7, 77.6)	58.5 (32.2, 70.3)	-2.23	0.026^c
部分凝血酶活化时间 (s)	36.5 (30.0, 48.4)	51.6 (35.5, 78.7)	-3.51	<0.001^c
纤维蛋白原 (g/L)	1. 6 (1.1, 2.2)	1.2 (0.8, 1.8)	-2.01	0.044^c
术中情况^a
手术时长 (min)	472.5 (407.5, 550.0)	485.0 (435.0, 560.0)	-1.64	0.100
功能性热缺血时间 (min)	3.0 (2.0, 3.0)	3.0 (3.0, 3.0)	-0.63	0.525
冷缺血时间 (h)	6.0 (4.0, 7.0)	6.0 (4.0, 8.0)	-0.06	0.952
无肝期时长 (min)	119.0 (101.3, 144.3)	130.0 (108.0, 155.0)	-1.42	0.155
红细胞输注量 (ml)	800.0 (0.0, 1 600.0)	1 600.0 (800.0, 2 100.0)	-3.63	<0.001^c
输血浆量 (ml)	800.0 (400.0, 800.0)	800.0 (800.0, 1 200.0)	-2.22	0.027^c
输液量 (ml)	5 100.0 (4 300.0, 6 300.0)	4 325.0 (3 525.0, 5 825.0)	-3.35	0.001^c
出血量 (ml)	800.0 (500.0, 1 200.0)	1 100.0 (800.0, 1 700.0)	-2.88	0.004^c
尿量 (ml)	1 668.8 (1 140.0, 2 200.0)	935.0 (462.5, 1 623.75)	-4.65	<0.001^c

变量	单因素分析			多因素分析
变量	OR	95% CI	P值	OR	95% CI	P值
MELD评分>20.8分	4.369	2.172~8.789	<0.001^a	1.923	0.847~4.364	0.118
合并酒精性肝硬化	2.685	1.159~6.220	0.021^a	2.403	0.912~6.327	0.076
合并腹腔感染	6.546	2.169~19.756	0.001^a	2.100	0.574~7.689	0.262
手术时长>432.5 min	2.446	1.229~4.867	0.011^a	1.509	0.632~3.606	0.354
无肝期时长>104.5 min	2.388	1.181~4.827	0.015^a	1.899	0.824~4.377	0.132
术中红细胞输注量>1 650 ml	4.668	2.312~9.427	<0.001^a	3.313	1.397~7.857	0.007^a
术中输液量≤4 375 ml	3.076	1.552~6.094	0.001^a	1.740	0.777~3.893	0.178
术中尿量≤1 115 ml	6.114	2.969~12.589	<0.001^a	3.245	1.409~7.473	0.006^a
术前血小板计数≤24.5×10⁹/L	6.899	2.911~16.346	<0.001^a	3.437	1.194~9.895	0.022^a
术前血糖≤4.8 mmol/L	2.640	1.288~5.412	0.008^a	2.955	1.286~6.791	0.011^a

变量	单因素分析			多因素分析
变量	OR	95% CI	P值	OR	95% CI	P值
MELD评分>20.8分	4.369	2.172~8.789	<0.001^a	1.923	0.847~4.364	0.118
合并酒精性肝硬化	2.685	1.159~6.220	0.021^a	2.403	0.912~6.327	0.076
合并腹腔感染	6.546	2.169~19.756	0.001^a	2.100	0.574~7.689	0.262
手术时长>432.5 min	2.446	1.229~4.867	0.011^a	1.509	0.632~3.606	0.354
无肝期时长>104.5 min	2.388	1.181~4.827	0.015^a	1.899	0.824~4.377	0.132
术中红细胞输注量>1 650 ml	4.668	2.312~9.427	<0.001^a	3.313	1.397~7.857	0.007^a
术中输液量≤4 375 ml	3.076	1.552~6.094	0.001^a	1.740	0.777~3.893	0.178
术中尿量≤1 115 ml	6.114	2.969~12.589	<0.001^a	3.245	1.409~7.473	0.006^a
术前血小板计数≤24.5×10⁹/L	6.899	2.911~16.346	<0.001^a	3.437	1.194~9.895	0.022^a
术前血糖≤4.8 mmol/L	2.640	1.288~5.412	0.008^a	2.955	1.286~6.791	0.011^a

[1]	Rouna Wu, Juehan Wang, Denghuang Fan, Wangxiao Bao, Lin Mao, Daming Wang. Effect of early ambulation on postoperative recovery in liver transplant patients admitted to ICU [J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2026, 19(02): 131-138.
[2]	Jianyong Liu, Yi Jiang. Application of immune checkpoint inhibitors neoadjuvant therapy in liver transplantation for hepatocellular carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2026, 20(02): 127-132.
[3]	·Aishanjiang Aizimanti, ·Tulahong Alimu, Qiang Guo, Ruiqing Zhang, ·Abduheli Abuduhaiwai’er, ·Aji Turganaili. Progress in the diagnosis and treatment of large-for-size liver syndrome in adult liver transplantation [J]. Chinese Archives of General Surgery(Electronic Edition), 2026, 20(02): 133-137.
[4]	Linpu Xin, Min Yang, Junfeng Du. Prevention and management of common complications after laparoscopic radical resection of colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(03): 248-251.
[5]	Heng Wang, Jinman Ma, Bisi Wang. Risk factor analysis and predictive model construction for complications after endovascular aortic repair of abdominal aortic aneurysm [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(03): 292-295.
[6]	Ruifeng Deng, Lu Cheng, Yuanling Liu, Qiuping Zheng, Xi Liu, Wencong Jiang, Minyao Jiang, Ming Xi. Constructing a predictive model for failure of first-stage ureteral access sheath placement based on Logistic regression [J]. Chinese Journal of Endourology(Electronic Edition), 2026, 20(02): 171-178.
[7]	Wenting Li, Huan Huang. Risk factors and preventive measures for hematoma formation after laparoscopic inguinal hernia repair surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2026, 20(03): 296-300.
[8]	Jianliang Yang, Ailing Zhang, Xiaoming Wang, Tianxing Dai, Feng Yuan, Canhua Zhu, Lan Lan, Hanyu Yang, Guoying Wang. Clinical application of fast-track anesthesia with early tracheal extubation after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 398-404.
[9]	Xiaoyong Ye, Lin Zhou. Progress in application of tolerant dendritic cells in immune tolerance of liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(03): 420-425.
[10]	Youjie Yan, Wuchang Wang, Fangbao Li, Min Wei, Hengzhu Zhang, Xiaodong Wang. Analysis of risk factors for lower extremity deep venous thrombosis formation in patients with basal ganglia hemorrhage after surgery [J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2026, 12(02): 86-91.
[11]	Yimei Han, Shichuan Feng, Zhijuan Chen. Risk factors for recurrence of hyperlipidemic acute pancreatitis and construction of a nomogram prediction model [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(03): 222-228.
[12]	Dawei Cheng, Hai Liang. Research on the risk early warning model of colonic diverticular disease based on Logistic regression and its value [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(03): 229-235.
[13]	Juanhua Sun, Yinmiao Bai, Shengnan Kong, Mengxue Wang, Wenhui Wang, Hongmei Zhang. Construction and verification of a nomogram of chemotherapy-related nausea and vomiting risk in patients with pancreatic cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(02): 114-119.
[14]	Weina Zhang, Yajuan Pan, Min Xu. Establishment of a nomogram risk predictive model for organ/space infection for patients with advanced digestive system cancer underwent surgery [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(02): 120-124.
[15]	Chenyang Li, Tao Wang, Zhongrui Xu, Fuxiu Huang, Shuling Li, Yan Xu, Xuan Zhou, Hui Zhao, Ningning Zhang, Chao Chen. Construction and validation of a risk score for safe discharge of patients with acute lower gastrointestinal bleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(02): 156-161.

Please choose a citation manager

Content to export